Showing results (171-180 of 889) with videos related to
Sort By:
Pageof 89
Cancer|June 15, 1991
Ganglioside GM3:GD3 ratio as an index for the management of melanomaM H Ravindranath, T Tsuchida, D L Morton, et al.Cellular Immunology|June 15, 1997
Recognition of gp43 tumor-associated antigen peptide by both HLA-A2 restricted CTL lines and antibodies from melanoma patientsT Takahashi, R F Irie, D L Morton, et al.Cancer|January 1, 1976
111Indium-bleomycin breast and axilla imagingM J Silverstein, R C Verma, L Greenfield, et al.Journal of Surgical Oncology|June 1, 1985
Effects of intralymphatic immunotherapy on natural killer activity in malignant melanoma patientsP M Moy, S H Golub, E Calkins, et al.Journal of the American College of Surgeons|July 18, 2000
Judging the therapeutic value of lymph node dissections for melanomaA D Chan, R Essner, L A Wanek, et al.Annals of Surgical Oncology|November 24, 1999
Increased incidence of second primary melanoma in patients with a previous cutaneous melanomaL A DiFronzo, L A Wanek, R Elashoff, et al.Cancer Immunology, Immunotherapy : CII|October 1, 1993
A protein fraction from aged garlic extract enhances cytotoxicity and proliferation of human lymphocytes mediated by interleukin-2 and concanavalin AN Morioka, L L Sze, D L Morton, et al.Journal of the National Cancer Institute|January 1, 1987
Gangliosides of human melanomaT Tsuchida, R E Saxton, D L Morton, et al.Journal of Endocrinological Investigation|March 1, 1991
Identification of a subgroup of Graves' disease patients at higher risk for severe ophthalmopathy after radioiodineA Barth, P Probst, H BürgiPageof 89